; Whereas 75 percent of States have reported an increase in the proportion of complex cases of TB in recent years due to factors such as homelessness, HIV infection, drug resistance, substance abuse, refugee status, and other factors; Whereas the rate of TB disease in African Americans is 8 times higher than the rate in White non-Hispanic Americans, and significant disparities exist among other minorities in the United States, including Native Americans and Alaska Natives, Asian Americans, and Hispanic Americans, with 86 percent of all reported TB cases in the United States in 2016 occurring in racial or ethnic minorities; Whereas, globally in 2016, an estimated 1,000,000 children developed TB and 250,000 children died of TB; Whereas smoking greatly increases the risk of death from TB, and more than 20 percent of TB cases worldwide may be attributable to smoking; Whereas diabetes is a major risk factor for TB, and people with diabetes are more likely to develop TB and have a higher risk of death due to TB; Whereas bedaquiline is an antibiotic that boosts an MDR-TB patient’s chance of survival from approximately 50 percent to as much as 80 percent, and through a public-private partnership, the United States Agency for International Development (commonly referred to as USAID ) assists more than 8,000 patients in almost 40 countries in accessing this new medication; Whereas Bacillus Calmette-Guerin, a TB vaccine that is known as BCG , provides some protection to children but has had little epidemiologic impact on TB worldwide; Whereas there is a critical need for new drugs, diagnostics, and vaccines for controlling the global TB epidemic; Whereas the WHO has called for “global solidarity and action” to support a 20-year strategy to end the global TB epidemic; Whereas the enactment of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 ( Public Law 110–293